Posted in | News | Minerals

EURODIF Permanently Ceases Production at Uranium Enrichment Facility

After 33 years of uninterrupted operation, EURODIF's Georges Besse enrichment plant, located in the Tricastin site in France's Drôme department and operated by AREVA, has permanently ceased production at the end of the shutdown process which began last May 14.


The EURODIF plant has been a showpiece in the global market for uranium ever since it was commissioned in 1979. Using the gaseous diffusion process, the most efficient enrichment technology at the time it was built, the site met demand from nearly 100 nuclear reactors around the world, the equivalent of one quarter of world demand.

AREVA invested more than 3 billion euros in recent years in the new Georges Besse II site to take over from EURODIF's historic Georges Besse plant. The new plant has been in production since April 2011 using the centrifugation enrichment technology, which consumes 50 times less electricity and considerably reduces cooling water requirements.

Already deployed in other European plants, this technology is both proven and efficient.

The Georges Besse II plant has already reached an installed capacity of more than 1.5 million SWU* per year; it will achieve its full production capacity of 7.5 million SWU per year in 2016.

Source: http://www.areva.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.